Argon Medical Devices, Inc. unveiled its CLEANERXT™ Rotational Thrombectomy System at the recent 2014 Society of Interventional Radiology meeting in San Diego. Now the company tells us it has begun marketing the system, which is a new addition to the CLEANER family of dialysis products.
According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), almost 400,000 patients undergo dialysis each year. An occupational hazard for patient and physician is the need for mechanical declotting of native vessel dialysis fistulae and synthetic dialysis access grafts. This thrombectomy procedure is the target for Argon Medical with its CLEANER device franchise.
As is the way with these things, once a company has a base technology we’re always likely to see iteration after iteration as the offering is developed and improved. So is the case with Argon’s CLEANER platform, which we first covered early in 2013 when its CLEANER15 was launched. CLEANER15 claimed increased torque compared with earlier systems, and it seems CLEANERXT has taken this a step further with yet more power and torque for cleaning wall-adherent thrombus, as well as the ability to be introduced through a 6 Fr sheath. As with CLEANER15, CLEANERXT combines torque with trackability, its innovative sinusoidal wire design being radiopaque and conforming to varying lumen diameters, actively cleaning wall-adherent thrombus.
“We continuously look at ways to improve our product offerings so that physicians can provide safe and effective therapy to their patients,” stated George Leondis, President of Argon Medical Devices. “CLEANERXT provides a tremendous combination of power and minimal invasiveness. Among wall-contacting thrombectomy devices, CLEANERXT provides physicians an unmatched ability to effectively macerate wall-adherent thrombus on a 6 Fr device platform.”
Source: Argon Medical, Inc., PR Newswire